Samit Hirawat
InvestorMedical Advisor at Abingworth
Find your path to Samit
Sign up to see every warm intro you have to Samit
- Paths you didn't know you had: your email and LinkedIn already hold routes to Samit. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Samit Hirawat, M.D., joined Abingworth in June 2026 as Medical Advisor, bringing background in drug development. He previously served as Chief Medical Officer and Head of Global Drug Development at Bristol Myers Squibb, overseeing product development across therapeutic areas, and earlier held senior roles at Novartis (EVP and Head of Oncology Development), PTC Therapeutics, and Pfizer. He earned his MBBS at Sawai Man Singh Medical College in India and completed internal medicine residency and medical oncology training at North Shore University Hospital in New York.
Invests in
Biotech
Investments
Board seats
Cytospire TherapeuticsK-2 Therapeutics, LLCPacira Biosciences
Per the firm's website.
Colleagues at Abingworth
Frequently asked questions
- Who is Samit Hirawat?
- Samit Hirawat, M.D., joined Abingworth in June 2026 as Medical Advisor, bringing background in drug development. He previously served as Chief Medical Officer and Head of Global Drug Development at Bristol Myers Squibb, overseeing product development across therapeutic areas, and earlier held senior roles at Novartis (EVP and Head of Oncology Development), PTC Therapeutics, and Pfizer. He earned his MBBS at Sawai Man Singh Medical College in India and completed internal medicine residency and medical oncology training at North Shore University Hospital in New York.
- Where does Samit Hirawat work?
- Samit Hirawat is Medical Advisor at Abingworth.
- What does Samit Hirawat invest in?
- Samit Hirawat invests in Biotech.
- What boards does Samit Hirawat sit on?
- Samit Hirawat holds tracked board seats at Cytospire Therapeutics, K-2 Therapeutics, LLC, Pacira Biosciences.
About this profile. Compiled from public sources — Abingworth's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights






